The Global Stem Cell Therapy For Diabetes Related Conditions market industry is primarily driven by the continuous advancements in technology.
Key market drivers of the Insulin Pen and Pump market include the rising prevalence of diabetes, advancements in insulin delivery technologies ...
Medtronic's stock lags peers due to growth challenges in the diabetes and hypertension markets. See why we recommend a sell ...
Medtronic is capturing demand for its cutting-edge solutions, as recent product launches emerge to drive new growth. With the ...
We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Medtronic (MDT – Research Report), Biohaven Ltd. (BHVN – ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Canopy Growth (CGC – Research Report), ...
Medtronic announces CMS national coverage analysis for Symplicityâ„¢ Spyral Renal Denervation System
This national coverage analysis was initiated by CMS in response to Medtronic's request to support Medicare beneficiary access to the Symplicityâ„¢ Spyral renal denervation (RDN) system ...
Investing.com -- Shares of Medtronic plc (NYSE:MDT) climbed 3% after the company announced that the Centers for Medicare & Medicaid Services (CMS) has initiated a national coverage analysis (NCA ...
Investing.com -- Shares of Medtronic plc (NYSE:MDT) climbed 3% after the company announced that the Centers for Medicare & Medicaid Services (CMS) has initiated a national coverage analysis (NCA) for ...
Medtronic said Monday the Centers for Medicare and Medicaid Services opened a national coverage analysis for renal denervation procedures in patients with high blood pressure. The policy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results